We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

158 hedge funds and large institutions have $254M invested in Immunogen Inc in 2016 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 53 increasing their positions, 32 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more call options, than puts

Call options by funds: $1.73M | Put options by funds: $893K

66% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 32

65% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 23

10% more funds holding

Funds holding: 143 → 158 (+15)

61% less capital invested

Capital invested by funds: $651M → $254M (-$397M)

Holders
158
Holders Change
+15
Holders Change %
+10.49%
% of All Funds
4.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
53
Reduced
32
Closed
23
Calls
$1.73M
Puts
$893K
Net Calls
+$836K
Net Calls Change
-$2.51M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$12.3M
2
Millennium Management
Millennium Management
New York
+$10.2M
3
Morgan Stanley
Morgan Stanley
New York
+$10M
4
Macquarie Group
Macquarie Group
Australia
+$8.65M
5
Deutsche Bank
Deutsche Bank
Germany
+$7.56M

Top Sellers

Rank Fund Capital Flow
1
Primecap Management
Primecap Management
California
-$17.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$14.4M
3
BBA
Baker Bros. Advisors
New York
-$9.01M
4
Invesco
Invesco
Georgia
-$8.14M
5
GC
Guggenheim Capital
Illinois
-$1.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
IWMPD
176
Integrated Wealth Management (Palm Desert)
California
– +$940 +150 New
4 5 6 7
8

IMGN Hedge Fund Activity: Q2 2016 in Review

158 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2016, worth a combined $254M — down 61% from $651M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new IMGN positions and 23 closed out — a net gain of 15 holders — while 53 added to existing stakes and 32 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $12.3M. The largest seller was Primecap Management, cutting an estimated $17.3M.

  • 158 institutional investors held Immunogen Inc (IMGN) as of Q2 2016, up from 143 in Q1 2016.
  • Funds reported $254M of Immunogen Inc stock for Q2 2016, down 61% quarter-over-quarter.
  • 38 funds opened new Immunogen Inc positions in Q2 2016 and 23 closed out, a net change of +15 holders.
  • The largest Immunogen Inc buyer in Q2 2016 was Renaissance Technologies, an estimated $12.3M added.
  • The largest Immunogen Inc seller in Q2 2016 was Primecap Management, an estimated $17.3M sold.

Based on aggregated 13F filings for Q2 2016.